Howard Burris : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (223)
Les plus populaires
Liste
- Liste
- Tableau

1

Clinical Implications of Pathophysiological and Demographic Covariates on the Population Pharmacokinetics of Trastuzumab Emtansine, a HER2-Targeted Antibody-Drug Conjugate, in Patients With HER2-Positive Metastatic Breast Cancer

Gupta, Manish, LoRusso, Patricia M., Wang, Bei, Yi, Joo-Hee, Burris, Howard A., Beeram, Muralidhar, Modi, Shanu, Chu, Yu-Waye, Agresta, Samuel, Klencke, Barbara, Joshi, Amita, Girish, Sandhya

Journal:

Journal of Clinical Pharmacology

Année:

2012

Langue:

english

Fichier:

PDF, 2.02 MB

english, 2012

2

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Hortobagyi, Gabriel N., Stemmer, Salomon M., Burris, Howard A., Yap, Yoon-Sim, Sonke, Gabe S., Paluch-Shimon, Shani, Campone, Mario, Blackwell, Kimberly L., André, Fabrice, Winer, Eric P., Janni, Wolf

Journal:

New England Journal of Medicine

Année:

2016

Langue:

english

Fichier:

PDF, 288 KB

english, 2016

3

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Burris, Howard A, Flinn, Ian W, Patel, Manish R, Fenske, Timothy S, Deng, Changchun, Brander, Danielle M, Gutierrez, Martin, Essell, James H, Kuhn, John G, Miskin, Hari P, Sportelli, Peter, Weiss, Mic

Journal:

The Lancet Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 334 KB

english, 2018

4

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Meric-Bernstam, Funda, Hurwitz, Herbert, Raghav, Kanwal Pratap Singh, McWilliams, Robert R, Fakih, Marwan, VanderWalde, Ari, Swanton, Charles, Kurzrock, Razelle, Burris, Howard, Sweeney, Christopher,

Journal:

The Lancet Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 1.31 MB

english, 2019

5

Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network trial

F. Anthony Greco, James R. Gray Jr., Dana S. Thompson, Howard A. Burris III, Joan B. Erland, John H. Barton Jr., Sharlene Litchy, Gerry A. Houston, James A. Butts, Charles Webb, Charles Scott, John D.

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 80 KB

english, 2002

6

Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors

Faye M. Johnson, Shruti Agrawal, Howard Burris, Lee Rosen, Navneet Dhillon, David Hong, Anne Blackwood-Chirchir, Feng R. Luo, Oumar Sy, Sanjeev Kaul, Alberto A. Chiappori

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 222 KB

english, 2010

7

Bevacizumab and everolimus in the treatment of patients with metastatic melanoma : A phase 2 trial of the Sarah Cannon Oncology Research Consortium

John D. Hainsworth, Jeffrey R. Infante, David R. Spigel, James D. Peyton, Dana S. Thompson, Cassie M. Lane, Bobby L. Clark, Mark S. Rubin, David F. Trent, Howard A. Burris III

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 197 KB

english, 2010

8

A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2–positive breast cancer

Muralidhar Beeram, Ian E. Krop, Howard A. Burris, Sandhya R. Girish, Wei Yu, Michael W. Lu, Scott N. Holden, Shanu Modi

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 417 KB

english, 2012

9

Does intraosseous equal intravenous? A pharmacokinetic study

Daniel D. Von Hoff, John G. Kuhn, Howard A. Burris III, Larry J. Miller

Journal:

The American Journal of Emergency Medicine

Année:

2008

Langue:

english

Fichier:

PDF, 615 KB

english, 2008

10

Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with erlotinib

Grace K. Dy, Jeffrey R. Infante, S. Gail Eckhardt, Silvia Novello, Wen Wee Ma, Suzanne F. Jones, Anne Huff, Qiong Wang, A. Benjamin Suttle, Lone H. Ottesen, Alex A. Adjei, Howard A. Burris III…show al

Journal:

Investigational New Drugs

Année:

2013

Langue:

english

Fichier:

PDF, 238 KB

english, 2013

11

Part-time curdling

Dauphinée, Michael J., Dang, Howard, Flescher, Eliezer, Wilson-Burris, Katharine, Galarza, Dionicio, Hempel, Karl, Talal, Norman

Journal:

Année:

2007

Langue:

english

Fichier:

PDF, 139 KB

english, 2007

12

Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2–Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study

Perez, Edith A., Barrios, Carlos, Eiermann, Wolfgang, Toi, Masakazu, Im, Young-Hyuck, Conte, Pierfranco, Martin, Miguel, Pienkowski, Tadeusz, Pivot, Xavier, Burris, Howard, Petersen, Jennifer A., Stan

Journal:

Journal of Clinical Oncology

Année:

2017

Langue:

english

Fichier:

PDF, 1.15 MB

english, 2017

13

Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort

Burris, Howard A, Bakewell, Suzanne, Bendell, Johanna C, Infante, Jeffrey, Jones, Suzanne F, Spigel, David R, Weiss, Glen J, Ramanathan, Ramesh K, Ogden, Angela, Von Hoff, Daniel

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 1.37 MB

english, 2017

14

TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies

Burris, Howard A., Kurkjian, C. D., Hart, L., Pant, S., Murphy, P. B., Jones, S. F., Neuwirth, R., Patel, C. G., Zohren, F., Infante, J. R.

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2017

Langue:

english

Fichier:

PDF, 606 KB

english, 2017

15

Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer

Rodon, Jordi, Pérez-Fidalgo, Alejandro, Krop, Ian E., Burris, Howard, Guerrero-Zotano, Angel, Britten, Carolyn D., Becerra, Carlos, Schellens, Jan, Richards, Donald A., Schuler, Martin, Abu-Khalaf, Ma

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2018

Langue:

english

Fichier:

PDF, 954 KB

english, 2018

16

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

Tap, William D., Villalobos, Victor M., Cote, Gregory M., Burris, Howard, Janku, Filip, Mir, Olivier, Beeram, Murali, Wagner, Andrew J., Jiang, Liewen, Wu, Bin, Choe, Sung, Yen, Katharine, Gliser, Cam

Journal:

Journal of Clinical Oncology

Année:

2020

Langue:

english

Fichier:

PDF, 730 KB

english, 2020

17

Extended RAS Analysis of the Phase 3 EPIC Trial: Irinotecan + Cetuximab vs Irinotecan as SecondâLine Treatment for Patients with Metastatic Colorectal Cancer

Sobrero, Alberto, Lenz, HeinzâJosef, Eng, Cathy, Scheithauer, Werner, Middleton, Gary, Chen, Wenfeng, Esser, Regina, Nippgen, Johannes, Burris, Howard

Journal:

Année:

2020

Fichier:

PDF, 625 KB

2020

18

Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer

John D. Hainsworth, Howard A. Burris III, Lisa H. Morrissey, F. Anthony Greco

Journal:

Année:

1999

Langue:

english

Fichier:

PDF, 72 KB

english, 1999

19

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

John D. Hainsworth, Howard A. Burris III, Joan B. Erland, Lisa H. Morrissey, Anthony A. Meluch, Leonard A. Kalman, Jeremy K. Hon, Daniel C. Scullin Jr., Steven W. Smith, F. Anthony Greco

Journal:

Année:

1999

Langue:

english

Fichier:

PDF, 84 KB

english, 1999

20

Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients : A Minnie Pearl Cancer Research Network Phase II trial

John D. Hainsworth, Howard A. Burris III, Sharlene Litchy, Joan B. Erland, Jeremy K. Hon, Joseph E. Brierre, F. Anthony Greco

Journal:

Année:

2000

Langue:

english

Fichier:

PDF, 76 KB

english, 2000

21

Testicular relapse in adult acute myelogenous leukemia

Don W. Shafer, Howard A. Burris, Timothy J. O'Rourke

Journal:

Année:

1992

Langue:

english

Fichier:

PDF, 566 KB

english, 1992

22

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial

John D. Hainsworth, Howard A. Burris III, Sharlene Litchy, Lisa H. Morrissey, John H. Barton, James E. Bradof, F. Anthony Greco

Journal:

Année:

2000

Langue:

english

Fichier:

PDF, 75 KB

english, 2000

23

Carcinoma of unknown primary site : Long term follow-up after treatment with paclitaxel, carboplatin, and etoposide

F. Anthony Greco, Howard A. Burris III, Joan B. Erland, James R. Gray, Leonard A. Kalman, Marshall T. Schreeder, John D. Hainsworth

Journal:

Année:

2000

Langue:

english

Fichier:

PDF, 81 KB

english, 2000

24

Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas : Results of a Phase II trial

John D. Hainsworth, Howard A. Burris III, Anthony A. Meluch, Margaret N. Baker, Lisa H. Morrissey, F. Anthony Greco

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 89 KB

english, 2001

25

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma : A feasibility study of the Minnie Pearl Cancer Research Network

F. Anthony Greco, Howard A. Burris III, James R. Gray, Eric L. Raefsky, Charles Dobbs, Steven Smith, David Rinaldi, Lisa H. Morrissey, Joan B. Erland, Sharlene Litchy, John D. Hainsworth

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 72 KB

english, 2001

26

Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma : Phase II trials of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Howard A. Burris III, Frederic T. Billings III, James E. Bradof, Margaret Baker, F. Anthony Greco

Journal:

Année:

2001

Langue:

english

Fichier:

PDF, 94 KB

english, 2001

27

Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung carcinoma : A Phase II trial of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Lisa H. Morrissey, Daniel C. Scullin Jr., Gerry Ann Houston, Edgar F. Prasthofer, James R. Gray, Howard A. Burris III, F. Anthony Greco

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 83 KB

english, 2002

28

A phase I trial of protracted oral fixed-dose temozolomide

Suzanne F. Jones, F. Anthony Greco, Victor G. Gian, Fernando T. Miranda, Eric L. Raefsky, John D. Hainsworth, Noel T. Willcutt, Aurelia F. Beschorner, Glyndon Kennerly, Howard A. Burris III

Journal:

Année:

2005

Langue:

english

Fichier:

PDF, 86 KB

english, 2005

29

Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck

John D. Hainsworth, David R. Spigel, Howard A. Burris III, Tiffanie M. Markus, Dianna Shipley, Michel Kuzur, Scott Lunin, F. Anthony Greco

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 228 KB

english, 2009

30

Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site : A phase 2 trial of the Sarah Cannon Oncology Research Consortium

John D. Hainsworth, David R. Spigel, Howard A. Burris III, Dianna Shipley, Cindy Farley, Ines M. Macias-Perez, John Barton, F. Anthony Greco

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 156 KB

english, 2010

31

Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0

Clark A. Burris, Suresh de Silva, Wade C. Narrow, Ann E. Casey, Louis T. Lotta Jr, Howard J. Federoff, William J. Bowers

Journal:

The Journal of Gene Medicine

Année:

2008

Langue:

english

Fichier:

PDF, 269 KB

english, 2008

32

Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors

Jean-Francois Marier, Leng Pheng, My My Trinh, Howard A. Burris III, Suzanne Jones, Kirsten Anderson, Serina Warner, David Porubek

Journal:

Journal of Pharmaceutical Sciences

Année:

2011

Langue:

english

Fichier:

PDF, 218 KB

english, 2011

33

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer

Donald L. Trump, Heather Payne, Kurt Miller, Johann S. de Bono, Joe Stephenson III, Howard A. Burris III, Faith Nathan, Maria Taboada, Thomas Morris, Andreas Hubner

Journal:

Année:

2011

Langue:

english

Fichier:

PDF, 259 KB

english, 2011

34

Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy

Robert L. Fine, Samir S. Shah, Thomas A. Moulton, Ing-Ru Yu, David R. Fogelman, Michael Richardson, Howard A. Burris, Brian L. Samuels, Chatchawin Assanasen, Prakash Gorroochurn, Hanina Hibshoosh, Man

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2007

Langue:

english

Fichier:

PDF, 341 KB

english, 2007

35

Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy

Ahmad Awada, Martine J. Piccart, Suzanne F. Jones, Ronald A. Peck, Thierry Gil, David Lebwohl, Chi-Yuan Wu, Howard A. Burris

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2009

Langue:

english

Fichier:

PDF, 358 KB

english, 2009

36

Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma

Donna E. Reece, Dan Sullivan, Sagar Lonial, Ann F. Mohrbacher, Gurkamal Chatta, Chaim Shustik, Howard Burris, Karthik Venkatakrishnan, Rachel Neuwirth, William J. Riordan, Michael Karol, Lisa L. von M

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2011

Langue:

english

Fichier:

PDF, 420 KB

english, 2011

37

Tanespimycin pharmacokinetics: a randomized dose-escalation crossover phase 1 study of two formulations

Howard A. Burris, David Berman, Bindu Murthy, Suzanne Jones

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2011

Langue:

english

Fichier:

PDF, 394 KB

english, 2011

38

Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer

Apostolia-Maria Tsimberidou, Nancy Lewis, Tony Reid, Howard Burris, Patrick Urban, Eugene Y. Tan, Suraj Anand, Cynthia Uehara, Razelle Kurzrock

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2011

Langue:

english

Fichier:

PDF, 243 KB

english, 2011

39

A drug interaction study evaluating the pharmacokinetics and toxicity of sorafenib in combination with capecitabine

Jeffrey R. Infante, Suzanne F. Jones, Johanna C. Bendell, F. Anthony Greco, Denise A. Yardley, Cassie M. Lane, David R. Spigel, John D. Hainsworth, Howard A. Burris III

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2012

Langue:

english

Fichier:

PDF, 219 KB

english, 2012

40

A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation

David A. Rinaldi, John G. Kuhn, Howard A. Burris, F. Andrew Dorr, Gladys Rodriguez, S. Gail Eckhardt, Suzanne Jones, James R. Woodworth, Sharyn Baker, Connie Langley, David Mascorro, Trent Abrahams, D

Journal:

Cancer Chemotherapy and Pharmacology

Année:

1999

Langue:

english

Fichier:

PDF, 142 KB

english, 1999

41

A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer

Denise Yardley, Howard Burris, Nancy Peacock, Eric Raefsky, Marianne Melnik, Roger Inhorn, Dianna Shipley, John Hainsworth

Journal:

Breast Cancer Research and Treatment

Année:

2010

Langue:

english

Fichier:

PDF, 171 KB

english, 2010

42

A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer

Hedy Lee Kindler, Howard A. Burris, Alan B. Sandler, Ira Anton Oliff

Journal:

Investigational New Drugs

Année:

2009

Langue:

english

Fichier:

PDF, 170 KB

english, 2009

43

A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors

Howard A. Burris, Suzanne F. Jones, Daphne D. Williams, Steven J. Kathman, Jeffrey P. Hodge, Lini Pandite, Peter T. C. Ho, Scott A. Boerner, Patricia LoRusso

Journal:

Investigational New Drugs

Année:

2011

Langue:

english

Fichier:

PDF, 167 KB

english, 2011

44

Phase II trial of topotecan in advanced gastric cancer: A Southwest Oncology Group study

Jacqueline K. Benedetti, Howard A. Burris III, Stanley P. Balcerzak, John S. Macdonald

Journal:

Investigational New Drugs

Année:

1997

Langue:

english

Fichier:

PDF, 22 KB

english, 1997

45

Phase I Study of JM-216 (an Oral Platinum Analogue) in Combination with Paclitaxel in Patients with Advanced Malignancies

Suzanne Jones, John Hainsworth, Howard A. Burris, Dana Thompson, Eric Raefsky, Valerie Johnson, Sharon Calvert, Cecile Bulanhagui, David Lebwohl, F. Anthony Greco

Journal:

Investigational New Drugs

Année:

2002

Langue:

english

Fichier:

PDF, 75 KB

english, 2002

46

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies

Howard A. Burris, Eric Raymond, Ahmad Awada, John G. Kuhn, Timothy J. O'Rourke, James Brentzel, William Lynch, Shang-Ying P. King, Thomas D. Brown, Daniel D. Von Hoff

Journal:

Investigational New Drugs

Année:

1998

Langue:

english

Fichier:

PDF, 322 KB

english, 1998

47

A phase I trial of vinorelbine in combination with mitoxantrone in patients with refractory solid tumors

Nancy W. Peacock, Howard A. Burris, Veronique Dieras, Lon Smith, Gladys I. Rodriguez, John R. Eckardt, Suzanne Fields Jones, Joanne Hardy, John Hohneker, Joseph Bigley, Daniel D. Von Hoff

Journal:

Investigational New Drugs

Année:

1998

Langue:

english

Fichier:

PDF, 87 KB

english, 1998

48

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody–drug conjugate in development for the treatment of HER2-positive cancer

Sandhya Girish, Manish Gupta, Bei Wang, Dan Lu, Ian E. Krop, Charles L. Vogel, Howard A. Burris III, Patricia M. LoRusso, Joo-Hee Yi, Ola Saad, Barbara Tong, Yu-Waye Chu, Scott Holden, Amita Joshi

Journal:

Cancer Chemotherapy and Pharmacology

Année:

2012

Langue:

english

Fichier:

PDF, 520 KB

english, 2012

49

14A A design for assessing clinical benefit for patients with advanced pancreatic cancer

John S. Andersen, Howard Burris, Ephraim Casper, Michael Clayman, Mark Green, Robert L. Nelson, Russell Portenoy, Mace Rothenberg, Peter G. Tarassoff, Daniel Von Hoff

Journal:

Controlled Clinical Trials

Année:

1994

Langue:

english

Fichier:

PDF, 54 KB

english, 1994

50

Hormonal Therapy Plus Bevacizumab in Postmenopausal Patients Who Have Hormone Receptor–Positive Metastatic Breast Cancer: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

Denise A. Yardley, Howard A. Burris III, Bobby L. Clark, Dianna Shipley, Mark Rubin, John Barton Jr, Edward Arrowsmith, John D. Hainsworth

Journal:

Clinical Breast Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 359 KB

english, 2011